Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0–1.7 µm) are in
high demand for precise theranostics that minimize autofluorescence, reduce photon …
high demand for precise theranostics that minimize autofluorescence, reduce photon …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy.
Y Sun, F Ding, Z Zhou, C Li, M Pu, Y Xu… - Proceedings of the …, 2019 - europepmc.org
Fluorescent theranostics probes at the second near-IR region (NIRII; 1.0–1.7 μm) are in high
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Y Sun, F Ding, Z Zhou, C Li, M Pu… - Proceedings of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0-1.7 µm) are in high
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Y Sun, F Ding, Z Zhou, C Li, M Pu… - Proceedings of the …, 2019 - ui.adsabs.harvard.edu
The biomedical applications of fluorescent anticancer agents in the first near-IR region (NIR-
I) have been hampered by problems of photostability, autofluorescence, and limited …
I) have been hampered by problems of photostability, autofluorescence, and limited …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Y Sun, F Ding, Z Zhou, C Li, M Pu, Y Xu, Y Zhan… - Proceedings of the …, 2019 - JSTOR
Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0–1.7 μm) are in
high demand for precise theranostics that minimize autofluorescence, reduce photon …
high demand for precise theranostics that minimize autofluorescence, reduce photon …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Y Sun, F Ding, Z Zhou, C Li, M Pu, Y Xu… - Proceedings of the …, 2019 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> The biomedical applications of fluorescent
anticancer agents in the first near-IR region (NIR-I) have been hampered by problems of …
anticancer agents in the first near-IR region (NIR-I) have been hampered by problems of …
[HTML][HTML] Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy
Y Sun, F Ding, Z Zhou, C Li, M Pu, Y Xu… - Proceedings of the …, 2019 - ncbi.nlm.nih.gov
Fluorescent theranostics probes at the second near-IR region (NIRII; 1.0–1.7 μm) are in high
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
Rhomboidal Pt (II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy.
Y Sun, F Ding, Z Zhou, C Li, M Pu, Y Xu… - Proceedings of the …, 2019 - europepmc.org
Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0-1.7 µm) are in high
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …
demand for precise theranostics that minimize autofluorescence, reduce photon scattering …